Novartis continues push into radiopharma with $745M Ratio deal
5 days ago · With two approved radioligand therapies on its commercial roster and a recent plan to boost its manufacturing for radiotherapeutics, Novartis AG tapped Ratio Therapeutics Inc. in …
OFF
Novartis Continues Push Into Radiopharma With $745M Ratio Deal
6 days from now
5 days ago · With two approved radioligand therapies on its commercial roster and a recent plan to boost its manufacturing for radiotherapeutics, Novartis AG tapped Ratio Therapeutics Inc. in …
bioworld.com
OFF
Novartis Strengthens Radiopharma Leadership With Ratio …
6 days from now
Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance radiopharmaceutical therapies.
msn.com
OFF
Novartis Taps Ratio For $745M Radiopharmaceutical Pact
6 days from now
Nov 15, 2024 · Novartis is adding another radiopharmaceutical program to its collection, penning a deal worth $745 million in biobucks for rights to a cancer candidate from Ratio Therapeutics. …
fiercebiotech.com
OFF
Novartis Strikes Radiopharma Deal With Ratio Worth Up To $745M
6 days from now
4 days ago · Novartis and Ratio Therapeutics announced a collaboration deal worth up to $745 million, focusing on SSTR2 radiotherapeutic cancer treatment. Ratio will receive an …
endpts.com
OFF
Novartis Signs Deal With Mass. Company Worth Up To $745M
6 days from now
4 days ago · Novartis’ interest in the hot area of radiopharmaceuticals is once again bringing it into contact with a Massachusetts company. Boston-based Ratio Therapeutics Inc. said on …
bizjournals.com
OFF
Novartis, Ratio To Collaborate On SSTR2 Radiotherapeutic For …
6 days from now
Under the deal, Ratio will receive up to $745M in upfront and potential milestone payments, plus tiered royalties on future sales. Ratio will collaborate with Novartis on preclinical activities to ...
msn.com
OFF
Novartis Drops Up To $745M To Move Deeper Into Competitive …
6 days from now
4 days ago · Novartis has struck a deal worth up to $745 million with Ratio Therapeutics for a radiopharmaceutical that could help defend its franchise from would-be challengers including …
biospace.com
OFF
Novartis Inks $745M Radiopharma Partnership With Ratio …
6 days from now
4 days ago · Novartis has also been examining Lutathera for other indications. In September, it released Phase 2 data on Lutathera improving progression-free survival in patients with …
mmm-online.com
OFF
Novartis Invests $745M To Compete With BMS And Lilly In The …
6 days from now
4 days ago · N ovartis has partnered with Ratio Therapeutics in a deal potentially worth up to $745 million to develop a radiopharmaceutical targeting somatostatin receptor 2 (SSTR2) for …
geneonline.com
OFF
Drugmakers Go Nuclear, Continuing Push Into …
6 days from now
Jun 10, 2021 · Within a year of the ABX deal, Novartis came knocking with its $2.1 billion takeover offer. ... E. Drugmakers go nuclear, continuing push into radiopharmaceuticals. Nat Biotechnol …
nature.com
OFF
Novartis To Spend $200M In Further Bid To Boost Radiopharma
6 days from now
Sep 4, 2024 · Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance The field has become a hot spot in drug development, leading to several …
statnews.com
OFF
Novartis News | Latest News - NewsNow
6 days from now
Novartis continues push into radiopharma with $745M Ratio deal BioWorld 22:41 Mon, 18 Nov Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks FierceBiotech …
newsnow.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
